General MedicationsORALStandard
RIDAURA
AURANOFIN
Standard Dose
3MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Prescription
Summary
Approval overview RIDAURA is listed in Drugs@FDA under application 018689 (NDA).
Review priority: PRIORITY Marketing status: Prescription Active ingredient AURANOFIN Form and strength CAPSULE;ORAL - 3MG Sponsor LEGACY PHARMA Submission history Latest submission status date: 2013-05-14 00:00:00.
Structured Monograph
Clinical summary
Approval overview RIDAURA is listed in Drugs@FDA under application 018689 (NDA). Review priority: PRIORITY Marketing status: Prescription Active ingredient AURANOFIN Form and strength CAPSULE;ORAL - 3MG Sponsor LEGACY PHARMA Submission history Latest submission status date: 2013-05-14 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: PRIORITY
Interaction Notes
- No interaction notes stored yet.